Members of the Loudoun Learners program have completed their first year of interning in the county’s Department of ...
Azul, Chainloop, Elastic, Expanso, F5 NGINX, Grafana Labs, Mattermost, Nirmata, Percona, Smallstep, and Tiger Data trust Chainguard for verifiably secure software with zero known ...
Kyle Kirkwood keeps taking it to the streets in IndyCar, and this time he won a new race to take over the series lead.
IndyCar is about to change how you experience qualifying drama. At the Java House Grand Prix of Arlington, the Firestone Fast Six will switch to a single-car, single-lap shootout that turns the pole ...
State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...
Nootbaar (heels) has been able to hit and throw without issue but is just now getting into the stage of being able to run unaided, Jeff Jones of the Belleville News-Democrat reports. Recovering from ...
When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...
BP has suspended its share buyback program and increased its cost-cutting goal by $1.5 billion to bolster its balance sheet and increase investment in oil production. The company's current struggles ...
Trump admin issues major new rule for truck drivers Descendant of enslaver uses eminent domain to target major Black-owned Georgia farm Nobel economist warns a dearth of blue-collar jobs is among the ...
A $5 million pilot program that supported free mental health clinics inside 23 public schools across the state is ending in June, leaving school officials and healthcare professionals scrambling to ...
BIG RAPIDS — Ferris State University’s online programs posted major gains in the latest U.S. News & World Report rankings, including a 159-place jump for its online bachelor’s degree programs and a ...
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.